Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of Pain With Radiesse® With Lidocaine for Nasolabial Folds

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Is at least 18 years of age~* Is a candidate for nasolabial fold treatment using Radiesse~* Has approximately symmetrical nasolabial folds~* Understands and accepts the obligation not to receive any other facial procedures in the lower half of the face for 1 month~Exclusion Criteria:~* Has received any type of treatment or procedures including surgery in the nasolabial folds~* Has received neurotoxin, hyaluronic acid, calcium hydroxylapatite (CaHA) or collagen injections in the lower half of the face within past 6 months~* Has received polylactic acid, polymethyl methacrylate (PMMA), silicone or any other permanent filler in the lower half of the face~* Has nasolabial folds that are too severe to be corrected in one treatment session~* Has any history of hypersensitivity to lidocaine or anesthetics of the amide type

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Radiesse® Mixed with Lidocaine (Type: EXPERIMENTAL): Injectable Dermal Filler. The same participants received the experimental device and the active comparator device at the same time (left and right sides of face).
- Radiesse® without Lidocaine (Type: ACTIVE_COMPARATOR): Injectable Dermal Filler. The same participants received the experimental device and the active comparator device at the same time (left and right sides of face).

Based on this trial design, predict the completion outcome and termination type (if applicable).